• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国和荷兰的 Barrett 食管和食管腺癌的发病率趋于平稳。

The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off.

机构信息

Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.

出版信息

Aliment Pharmacol Ther. 2014 Jun;39(11):1321-30. doi: 10.1111/apt.12759. Epub 2014 Apr 16.

DOI:10.1111/apt.12759
PMID:24738722
Abstract

BACKGROUND

Barrett's oesophagus (BO) is a risk factor for oesophageal adenocarcinoma (OAC). Several studies report increasing incidences of BO with substantial variation.

AIM

To determine age- and sex-stratified incidence rates (IR) of BO and OAC.

METHODS

Cohort study using two primary care databases in the United Kingdom (UK) and the Netherlands (NL) (2000-2012). BO and OAC cases were identified using disease-specific READ codes (UK) and free-text search with manual validation (NL). Age- and sex-specific incidence rates (IRs) were calculated for both BO and OAC.

RESULTS

From the study population of 6,885,420 subjects in the UK, we identified 12,312 incident BO and 40 (0.3%) subsequent incident OAC cases. There were 1383 incident BO, and subsequent 5 (0.4%) incident OAC cases among the 1,487,191 subjects in the NL. The IR of BO increased linearly with age: 15.6/100,000 PYs (UK) and 23.7/100,000 PYs (NL) for patients aged 40-44 years, increasing to 85.6/100,000 PYs (UK) and 87.0/100,000 PYs (NL) for 70-74 years. In both the UK and the NL, IR of BO was 2-4 times higher in males than females across all age groups. With respect to calendar time, the IR of BO increased by 35% (UK) and 41% (NL) from 2000 to 2003, after which IRs remained stable until 2012.

CONCLUSIONS

The incidence rates of BO in the UK and the NL increased until 2003, but levelled off thereafter. Around 0.3% of patients with BO developed OAC at least 1 year after BO diagnosis. These findings may help tailor endoscopic surveillance strategies among patients with BO.

摘要

背景

巴雷特食管(BO)是食管腺癌(OAC)的危险因素。多项研究报告称,BO 的发病率不断上升,且存在较大差异。

目的

确定 BO 和 OAC 的年龄和性别分层发病率(IR)。

方法

本研究采用英国(UK)和荷兰(NL)的两个初级保健数据库进行队列研究(2000-2012 年)。使用特定疾病的 READ 代码(UK)和带有手动验证的自由文本搜索(NL)识别 BO 和 OAC 病例。计算了 BO 和 OAC 的年龄和性别特异性发病率(IR)。

结果

在 UK 的 6885420 名研究人群中,我们发现了 12312 例新发病例 BO 和 40 例(0.3%)随后发生的 OAC 病例。在 NL 的 1487191 名患者中,有 1383 例新发病例 BO 和随后的 5 例(0.4%)新发病例 OAC。BO 的发病率随年龄呈线性增加:40-44 岁患者为 15.6/100,000 PYs(英国)和 23.7/100,000 PYs(NL),增加到 70-74 岁患者的 85.6/100,000 PYs(英国)和 87.0/100,000 PYs(NL)。在英国和 NL,所有年龄段的男性 BO 发病率均为女性的 2-4 倍。就日历时间而言,2000 年至 2003 年,BO 的发病率在英国增加了 35%(NL),在 NL 增加了 41%,此后发病率一直保持稳定,直到 2012 年。

结论

英国和 NL 的 BO 发病率在 2003 年之前一直在上升,但此后趋于平稳。大约 0.3%的 BO 患者在 BO 诊断后至少 1 年会发展为 OAC。这些发现可能有助于为 BO 患者量身定制内镜监测策略。

相似文献

1
The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off.英国和荷兰的 Barrett 食管和食管腺癌的发病率趋于平稳。
Aliment Pharmacol Ther. 2014 Jun;39(11):1321-30. doi: 10.1111/apt.12759. Epub 2014 Apr 16.
2
NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case-control study.非甾体抗炎药、他汀类药物、低剂量阿司匹林和质子泵抑制剂与巴雷特食管患者发生食管腺癌的风险:一项基于人群的病例对照研究。
BMJ Open. 2015 Jan 29;5(1):e006640. doi: 10.1136/bmjopen-2014-006640.
3
The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital.英国一家区综合医院四十年来巴雷特食管监测的演变与结果
Eur J Gastroenterol Hepatol. 2016 Dec;28(12):1365-1373. doi: 10.1097/MEG.0000000000000730.
4
Risk of oesophageal adenocarcinoma in individuals with Barrett's oesophagus.巴雷特食管患者发生食管腺癌的风险。
Eur J Cancer. 2017 Apr;75:41-46. doi: 10.1016/j.ejca.2016.12.037. Epub 2017 Feb 17.
5
Adam, Eve and the reflux enigma: age and sex differences across the gastro-oesophageal reflux spectrum.亚当、夏娃与反流之谜:胃食管反流谱中的年龄和性别差异
Eur J Gastroenterol Hepatol. 2017 Jun;29(6):634-639. doi: 10.1097/MEG.0000000000000845.
6
Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.巴雷特食管患者发生恶性进展的风险:一项荷兰全国性队列研究。
Gut. 2010 Aug;59(8):1030-6. doi: 10.1136/gut.2009.176701.
7
Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression.监测 Barrett 食管对肿瘤分期和肿瘤进展患者生存的影响。
Gut. 2016 Apr;65(4):548-54. doi: 10.1136/gutjnl-2014-308802. Epub 2015 Apr 22.
8
Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis.长段 Barrett 食管患者的监测:成本效益分析。
Gut. 2015 Jun;64(6):864-71. doi: 10.1136/gutjnl-2014-307197. Epub 2014 Jul 18.
9
The minimal incubation period from the onset of Barrett's oesophagus to symptomatic adenocarcinoma.从 Barrett 食管发病到有症状的腺癌的最短潜伏期。
Br J Cancer. 2011 Jul 12;105(2):200-5. doi: 10.1038/bjc.2011.214. Epub 2011 Jun 14.
10
The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis.非异型增生性 Barrett 食管中食管腺癌的发病率:一项荟萃分析。
Gut. 2012 Jul;61(7):970-6. doi: 10.1136/gutjnl-2011-300730. Epub 2011 Oct 13.

引用本文的文献

1
Long-term risk factors for developing Barrett's oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study.胃食管反流病患者发展为 Barrett 食管的长期风险因素:一项纵向队列研究。
BMJ Open Gastroenterol. 2024 Mar 22;11(1):e001307. doi: 10.1136/bmjgast-2023-001307.
2
Single-Cell RNA Sequencing Unifies Developmental Programs of Esophageal and Gastric Intestinal Metaplasia.单细胞 RNA 测序统一了食管和胃肠化生的发育程序。
Cancer Discov. 2023 Jun 2;13(6):1346-1363. doi: 10.1158/2159-8290.CD-22-0824.
3
Incidence and prevalence of eosinophilic oesophagitis: Are we reaching a plateau?
嗜酸性粒细胞性食管炎的发病率和患病率:我们是否已趋于平稳?
United European Gastroenterol J. 2022 Sep;10(7):623-624. doi: 10.1002/ueg2.12282. Epub 2022 Aug 15.
4
Data Resource Profile: The Integrated Primary Care Information (IPCI) database, The Netherlands.数据资源简介:荷兰综合初级保健信息(IPCI)数据库
Int J Epidemiol. 2022 Dec 13;51(6):e314-e323. doi: 10.1093/ije/dyac026.
5
Challenges in Determining the Role of Microbiome Evolution in Barrett's Esophagus and Progression to Esophageal Adenocarcinoma.确定微生物群进化在巴雷特食管及进展为食管腺癌过程中的作用所面临的挑战
Microorganisms. 2021 Sep 22;9(10):2003. doi: 10.3390/microorganisms9102003.
6
Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041.荷兰食管癌发病率的趋势和预测:1989 年至 2041 年的年龄-时期-队列分析。
Int J Cancer. 2022 Feb 1;150(3):420-430. doi: 10.1002/ijc.33836. Epub 2021 Oct 16.
7
Wide-area transepithelial sampling in adjunct to forceps biopsy increases the absolute detection rates of Barrett's oesophagus and oesophageal dysplasia: a meta-analysis and systematic review.广泛的跨上皮采样联合活检可提高 Barrett 食管和食管异型增生的绝对检出率:荟萃分析和系统评价。
BMJ Open Gastroenterol. 2020 Sep;7(1). doi: 10.1136/bmjgast-2020-000494.
8
The global prevalence of Barrett's esophagus: A systematic review of the published literature.全球 Barrett 食管的患病率:文献综述。
United European Gastroenterol J. 2020 Nov;8(9):1086-1105. doi: 10.1177/2050640620939376. Epub 2020 Jul 6.
9
Barrett's esophagus patients are becoming younger: analysis of a large United States dataset.巴雷特食管患者越来越年轻化:一项美国大型数据集的分析。
Esophagus. 2020 Apr;17(2):190-196. doi: 10.1007/s10388-019-00707-7. Epub 2020 Jan 1.
10
Natural History of Barrett's Esophagus.巴雷特食管的自然史。
Dig Dis Sci. 2018 Aug;63(8):1997-2004. doi: 10.1007/s10620-018-5161-x.